price
CR
NASDAQ · CRVS
Corvus Pharmaceuticals, Inc.
Healthcare · Biotechnology
$10.74
Down-$0.18 (-1.68%)
Updated Oct 7, 2026, 1:05 AM
SID Score
5.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 627.78M
- P/E ratio
- -46.21
- Dividend yield
- 0.00%
- 52-week range
- $6.39 – $26.95
- Volume
- 825.39K
- Avg. volume
- 1.02M
Price performance · CRVS
CRVS price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 5, 2026
CRVS closed at $10.74 after 20 trading sessions, down 22.90% for the selected period.
- Last close
- $10.74
- Period change
- -22.90%
- Period low
- $10.74
- Period high
- $13.93
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 5, 2026 | $10.88 | $11.145 | $10.45 | $10.74 | 825.39K |
| Oct 2, 2026 | $11.11 | $11.11 | $10.64 | $10.90 | 1.35M |
| Oct 1, 2026 | $11.56 | $11.75 | $10.89 | $10.93 | 1.31M |
| Sep 30, 2026 | $11.995 | $12.03 | $11.50 | $11.52 | 875.85K |
| Sep 29, 2026 | $12.365 | $12.42 | $11.72 | $11.76 | 881.95K |
| Sep 28, 2026 | $11.66 | $12.12 | $11.25 | $11.87 | 1.21M |
| Sep 25, 2026 | $11.92 | $12.04 | $11.415 | $11.62 | 1.1M |
| Sep 24, 2026 | $12.46 | $12.475 | $11.505 | $11.80 | 1.14M |
| Sep 23, 2026 | $13.30 | $13.4469 | $12.245 | $12.54 | 946.68K |
| Sep 22, 2026 | $12.55 | $13.46 | $12.35 | $13.44 | 806.63K |
| Sep 21, 2026 | $12.80 | $12.80 | $12.275 | $12.42 | 939.79K |
| Sep 18, 2026 | $12.53 | $12.61 | $12.25 | $12.56 | 4.46M |
| Sep 17, 2026 | $12.55 | $12.82 | $12.425 | $12.55 | 1.53M |
| Sep 16, 2026 | $13.00 | $13.145 | $12.18 | $12.23 | 952.27K |
| Sep 15, 2026 | $13.07 | $13.17 | $12.45 | $12.95 | 1.4M |
| Sep 14, 2026 | $12.92 | $13.305 | $12.905 | $13.11 | 1.09M |
| Sep 11, 2026 | $13.13 | $13.495 | $12.7702 | $12.91 | 1.26M |
| Sep 10, 2026 | $13.06 | $13.135 | $12.82 | $12.94 | 1.09M |
| Sep 9, 2026 | $13.76 | $13.905 | $12.95 | $13.33 | 1.11M |
| Sep 8, 2026 | $14.01 | $14.32 | $13.85 | $13.93 | 1.03M |
Latest CRVS news
The latest Smart Investors Daily articles mentioning CRVS.
Stock researchResearch & News · Competitors
Company
Market Activity
Research & News
Loading stock research…

